Controllable conformation and reactivity of bicyclic α-methylene cyclopentanones and their NF-κB pathway inhibitory activity.


Journal

Organic & biomolecular chemistry
ISSN: 1477-0539
Titre abrégé: Org Biomol Chem
Pays: England
ID NLM: 101154995

Informations de publication

Date de publication:
07 06 2023
Historique:
medline: 8 6 2023
pubmed: 22 5 2023
entrez: 22 5 2023
Statut: epublish

Résumé

Tuning the electrophilicities of Michael acceptors is important for the development of targeted covalent drugs. To this end, the electronic effects of electrophilic structures have been well investigated, but not the steric effects. In this work, we synthesized ten α-methylene cyclopentanones (MCPs), screened them for NF-κB inhibitory activity, and analyzed their conformations. We found that MCP-4b, MCP-5b, and MCP-6b are novel NF-κB inhibitors, whereas the corresponding diastereomers MCP-4a, MCP-5a, and MCP-6a are inactive. Conformational analysis suggested that the stereochemistry of the side chain (R) on MCPs dictates the stable conformation of the core bicyclic 5/6 ring system. The conformational preference seemed to influence their reactivity toward nucleophiles. Consequently, a thiol reactivity assay showed that MCP-5b has higher reactivity than MCP-5a. The results indicate that the conformational switching of MCPs may control reactivity and bioactivity in the presence of steric effects.

Identifiants

pubmed: 37212260
doi: 10.1039/d3ob00357d
doi:

Substances chimiques

NF-kappa B 0
cyclopentanone 220W81TN3S
Cyclopentanes 0
Sulfhydryl Compounds 0
Chemokine CCL2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4656-4660

Auteurs

Aki Kohyama (A)

Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. aki.kohyama.d5@tohoku.ac.jp.

Aya Shiuchi (A)

Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. aki.kohyama.d5@tohoku.ac.jp.

Yue Zhou (Y)

Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. aki.kohyama.d5@tohoku.ac.jp.

Masaru Tanioka (M)

Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. aki.kohyama.d5@tohoku.ac.jp.

Kenji Sugimoto (K)

Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. aki.kohyama.d5@tohoku.ac.jp.

Hiroaki Sakurai (H)

Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. aki.kohyama.d5@tohoku.ac.jp.

Yuji Matsuya (Y)

Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. aki.kohyama.d5@tohoku.ac.jp.

Articles similaires

Animals Lung India Sheep Transcriptome
Endometriosis Female Humans Animals Mice
Animals Osteoarthritis Rats NF-kappa B Male
Vinca Alkaloids Animals Carcinoma, Hepatocellular Rats Liver Neoplasms

Classifications MeSH